Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
GLP-1-mediated Gluco-metabolic Effects of Bile Acid Sequestration
NCT03739268Completed
- Sponsor
- Steno Diabetes Center Copenhagen
- Start
- Sep 2018
- Primary completion
- Sep 2020
- Modality
- Polymer-based Nanoparticles, Small Molecules
- Countries
- 1
01
Overview
Randomised trial in type 2 diabetes mellitus (T2DM) comparing Sevelamer with Placebo (2 arms). Primary endpoint: Postprandial plasma glucose excursion. Started Sep 2018; status: completed.
02
Drugs
sevelamer carbonate
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT03739268.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03739268.